Ethinyl Estradiol and Norgestimate 2012 U.S. Sales Exceed $425 Million


Ethinyl Estradiol
Ethinyl Estradiol CAS# 57-63-6

Ethinyl Estradiol, CAS number 57-63-6 and Norgestimate, CAS number 35189-28-7, are both integral components in the blockbuster birth control pill Ortho Tri-Cyclen Lo. Mylan and Janssen, who market Ortho Tri-Cyclen Lo, reported an astounding 425.5 million dollars in sales for the United States for the 2012 year. With the patent for this successful birth control pill expiring on June 9, 2019, research and development has already begun for generic options of Ortho Tri-Cyclen Lo. As a birth control medication, used to prevent pregnancy Ortho Tri-Cyclen Lo is a combination medication. This combination medication contains female hormones that prevent ovulation and cause changes in the cervical mucus and uterine lining, making it harder for sperm to reach the uterus and also harder for a fertilized egg to attach to the uterus.

Norgestimate
Norgestimate CAS# 35189-28-7

Patients who have a history of uncontrolled high blood pressure, heart disease, a blood-clotting disorder, circulation problems or a previous heart attack, stroke or blood clot caused by a birth control pill you should not take Ortho Tri-Cyclen Lo. Women who smoke or are over the age of 35 should not be administered Ortho Tri-Cyclen Lo, as their risk of stroke and heart attack is significantly increased. It is normal for patients taking Ortho Tri-Cyclen Lo to experience breakthrough bleeding, especially during the first 3 months of treatment. Typical side effects of Ortho Tri-Cyclen Lo include bloating, weight gain, mild dizziness, nausea and a darkening of facial skin. The benefit for women who are taking Ortho Tri-Cyclen Lo is that it is an effective, safe and tolerable method for birth control that contains an extremely low level of hormones.

LGM Pharma provides Ethinyl Estradiol and Norgestimate for research and development purposes, as well as the Norgestimate TEVA API for compounding purposes in the U.S.. Clients can be assured of quality API products and continuous support throughout the R&D process.

 

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
Bullets:

Ethinyl Estradiol, CAS number 57-63-6 and Norgestimate (TEVA API), CAS number 35189-28-7,  are both integral components in the blockbuster birth control pill Ortho Tri-Cyclen Lo.

Ortho Tri-Cyclen Lo reported an astounding 425.5 million dollars in sales for the United States for the 2012 year.

The benefit for women taking Ortho Tri-Cyclen Lo is that it is an effective, safe and tolerable method for birth control that contains an extremely low level of hormones.

Ranexa
  • Share: